Cassidy Skeptical Of FDA’s Approach To CDS Software Regulation

By Jessica Karins, Luke Zarzecki / April 18, 2024 at 6:21 PM
The top Republican on the Senate health committee is criticizing FDA’s approach to regulating clinical decision support (CDS) software, asking the agency for more information about how it crafted its guidance on the technology and whether it has documentation of threats posed to patients. Sen. Bill Cassidy (R-LA), the ranking Republican on the Senate Health, Education, Labor and Pensions Committee, wrote in a letter to FDA Commissioner Robert Califf that FDA’s guidance classifying some CDS software as medical devices subjects...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.